Oestrogens administered in lower doses than necessary to 
performed with this method. Their estimated relative potencies were in good agreement with other routine oestrogen assays. A statistically sufficient degree of precision was found. The sensitivity was of the same order, or slightly higher, than the Allen-Doisy test.
In the previous study (Part I, Carlborg 1969 ) the action of diethylstilboestrol (DES) was studied with regard to the sialic acid (SA) content of the mouse vagina and concomitant histological changes. It was demonstrated that this oestrogen caused a dose dependent decrease in SA concentration. The present study used this characteristic mode of reaction of the mouse vagina as an assay for the relative potency in a number of oestrogenic compounds.
METHODS
Female mice (NMRI strain) of about 25 g bodyweight were spayed and then allowed to rest for ten days. All test compounds were dissolved in sesame oil (except oestriol which was dissolved in saline), the daily dose being contained in 0.1 ml. Subcutaneous injections were made into the interscapular region once daily for three days. Force feeding was instigated using a suitable plastic tube inserted into the stomac of the animal. About 24 h after the last dose the animals were sacrificed by a blow on the head, the vaginae were then dissected out and immediately weighed wet on a torsion balance. The samples were ground in a tissue homogenizer in 1.25 ml of distilled water. The analysis of SA was performed using the Direct Ehrlich Method (Werner Se Odin 1952; Carlborg 1966 
DISCUSSION
In a previous study (Part I) on DES, the principles for the assay were dis¬ cussed. Each of the compounds tested in the present study (Part II) caused the same vaginal changes in SA concentration as did DES, but the dose levels at which these changes could be observed varied between the compounds. The possibility of using this characteristic vaginal reaction as an assay of oestrogen potency was evaluated in this study. Statistical treatment of the data showed that the index of precision ( ) varied from -0.061 to -0.25 with a mean value of -0.14. This figure was of the same magnitude as that found in other routine assays of oestrogen potency in laboratory animals (Dorfman Sc Dorfman 1954) . The spread of results within an experimental group was narrow enough to conclude that 5 animals per group provided sufficient information. The statis-tical evaluation of parallelism between all slopes indicated a similar action in the compounds tested.
The reproducibility of the method was tested by comparison with the data obtained for OEo in the author's previous paper (Carlborg 1966) . In this study, the doses had not been selected according to the criteria in the present assay, but the data lent themselves to calculation of the slope and the estimation of MED. Control mice had a mean SA concentration of 2.45 ßglmg and the low concentration at comparatively high oestrogen levels was 0.95 ßg/vag. The range for useful investigation was thus 1.50 µg/mg. The slope was calculated to be -1.38 which was a lower value than that found in the present study. With this exception the statistical data from the two investigations agreed closely as did the MED which was calculated to be 0.011 µg (c. f. 0.017 ßg in the present assay).
Using spayed mice and Allen-Doisy technique, the activities of the three natural oestrogens following subcutaneous administration were determined (Emmens 1939«,c As shown above, the oral MED for EOE¿ was 28 times higher than the subcutaneous MED. The corresponding figure for mestranol was 4.6. These data indicate a comparatively higher oral activity for mestranol than for EOEo if related to the subcutaneous MED.
The oestrogenic action of F 6066 and F 6103 has been tested by Einer-Jensen (1965 , 1968 . He used the mouse uterus test and determined the MED of these compounds and compared them with the corresponding MED for oestradiol benzoate. The data on absolute doses were not readily comparable with those in the present assay. He estimated oestradiol benzoate to be about 1000 times more potent than F 6066 and F 6103 to be 20 times more potent. The present study using the concentration of vaginal SA indicated a similar ratio of activity between F 6066 and F 6103, the latter being 18 times more active and OE2 times more active. The difference may be explained by the fact that Einer-Jensen (1965, 1968) used oestradiol benzoate instead of OE» and used a different end point.
